Literature DB >> 16956807

Zoledronic acid for the treatment of thalassemia-induced osteonecrosis.

Pat Mahachoklertwattana1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956807

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  1 in total

Review 1.  Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review.

Authors:  M Mamtani; H Kulkarni
Journal:  Osteoporos Int       Date:  2009-02-26       Impact factor: 4.507

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.